Teva
Mega deal: Teva acquires Emalex for approximately $900 million
The Israeli pharmaceutical giant is accelerating its growth strategy and adding to its portfolio a groundbreaking treatment for Tourette syndrome in children.
IATI CEOs Forum meets in Kiryat Gat to discuss multinational industry resilience
Teva honored for gender equality as women reach 43% of senior management in Israel
Teva collaborates on skin disease treatment, releases targets
Moderna’s outgoing Israeli chief medical officer joins TEVA board
Dr. Tal Zaks will serve on the Teva board's science and technology committee.
Israel's Teva in talks to co-produce COVID-19 vaccines
Teva, the world's largest generics drugmaker, both approached and was approached by vaccine makers.
Meet the hospital staff's children joining the fight against coronavirus
The children have been developing their projects as part of the "Biotech - Next Generation" project.
Teva collaborates with Technion in fields of cancer, neurobiology
Teva has already initiated collaborations with leading academic institutions, including Tel Aviv University, the Weizmann Institute of Science, and more.
Israeli researchers provide evidence microdosing cannabis relieves pain
The researchers published their findings in the European Journal of Pain, providing the first scientific evidence that microdosing can be applied medical cannabis solution.
Teva Israel sues Abbott over baby formula
Teva is claiming that Abbott Israel, a local entity which imports Similac, is behind a “mendacious and covert slur campaign” on social media.
Teva Naot opens fourth branch in Japan
Teva Naot markets about 100 different models of Japanese women’s fashion shoes.
Florida has not distributed most of hydroxychloroquine doses from Israel
Only a handful of hospitals have requested access to the hydroxychloroquine stockpile, according to the report.
Teva gets approval in China for Huntington's disease treatment
Teva’s CEO Kare Schultz said the drug would be priced somewhat lower in China than in the United States.
Teva's profit beats forecasts, shares jump
Shares in the world’s largest generic drugmaker jumped nearly 20% in late Tel Aviv trade as the company also reaffirmed its 2020 outlook, despite disruption to the global economy from the coronavirus